JAK2 V617F Mutation Analysis

Last Modified: 12/30/2020 7:40:10 AM

Specimen Requirements: 5.0 mL Whole Blood in a Lavender Top Tube - EDTA
Minimum Volume: 3.0 mL Whole Blood EDTA
Transport & Storage: Temperature/Stability: 7 days Ambient
7 days Refrigerated
Reference Range: Refer to Interpretive Results
Methodology: Polymerase Chain Reaction-based DNA Sequencing
Clinical Significance: This DNA-based assay tests leukocytes from blood or bone marrow aspirate for mutation at codon 617 of JAK2, using an advanced DNA sequencing method. The JAK2 V617F mutation is associated with myeloproliferative neoplasms, including polycythemia vera, essential thrombocythemia and primary myelofibrosis
Custom Panel: No


Turn Around Time: 5 to 7 days
Days Performed: Sunday, Monday, Tuesday, Wednesday, Thursday, Friday, Saturday
Sites Performed: Quest - Chantilly
PHL Test Code: JV617
EPIC Test Code: LAB3188
Send Out Test Code: 92473
Alternate Test Names: Essential Thrombocythemia (ET); ET; Myeloproliferative neoplasm; PMF; Polycythemia Vera (PV); Primary Myelofibrosis (PMF); PV
CPT Coding: 81270

Go back to the top of the page.